Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Satheesh B Ravula

1PUBLICATIONS
6CO-AUTHORS
Naturopathy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Nov 23, 2023
Lysophosphatidic acid receptor 1 antagonist (EPGN2154) causes regression of NASH in preclinical NASH models.

Jashdeep Bhattacharjee, Graham Beaton, Satheesh B Ravula

Pageof 1

Frequent Collaborators

1 joint publications

Jashdeep Bhattacharjee

1 joint publications

Graham Beaton

1 joint publications

Kevin B Bacon

1 joint publications

Mikako Warren

1 joint publications

Fabio C Tucci

1 joint publications

Rohit Kohli

Frequent Collaborators

1 joint publications

Jashdeep Bhattacharjee

1 joint publications

Graham Beaton

1 joint publications

Kevin B Bacon

1 joint publications

Mikako Warren

Top Related Videos

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

Published on : Apr 16, 2019

12.0K
See more related videos

Top Related Videos

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

Published on : Apr 16, 2019

12.0K
See more related videos